Paradigm Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$158K Buy
+300
New +$168K 0.03% 278
2022
Q2
Sell
-300
Closed -$164K 433
2022
Q1
$164K Hold
300
0.04% 299
2021
Q4
$198K Hold
300
0.05% 298
2021
Q3
$187K Sell
300
-100
-25% -$67.2K 0.05% 307
2021
Q2
$253K Sell
400
-100
-20% -$55.2K 0.06% 310
2021
Q1
$245K Sell
500
-100
-17% -$50.1K 0.07% 312
2020
Q4
$300K Buy
+600
New +$268K 0.08% 310

Other funds holding IDXX

Paradigm Asset Management's IDXX Position: Q2 2026 in Review

Paradigm Asset Management opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 300 shares worth $158K. The stake represents 0.03% of the portfolio and ranks #278 among its holdings. This is a return to the name: Paradigm Asset Management previously reported a position in IDXX as recently as Q1 2022.

Paradigm Asset Management first reported a position in IDXX in Q4 2020 and has held it in 7 quarters since. The position peaked at $300K in Q4 2020. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Paradigm Asset Management held 300 shares of Idexx Laboratories worth $158K as of Q2 2026.
  • Idexx Laboratories was a new Paradigm Asset Management position in Q2 2026.
  • Idexx Laboratories made up 0.03% of Paradigm Asset Management's portfolio in Q2 2026, its #278 holding.
  • Paradigm Asset Management first reported a position in Idexx Laboratories in Q4 2020 and has held it in 7 quarters since.
  • Paradigm Asset Management's Idexx Laboratories position peaked at $300K in Q4 2020.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Paradigm Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.